Search
Now showing items 1-9 of 9
Papers presented at events
Pharmacovigilance Committee for COVID-19 vaccine (ChAdOx1-S [recombinant]) and its contribution for an effective benefit-risk assessment
| Date Issued:
2022 | Copyright:
open access
Papers presented at events
Situational strategic planning of the pharmacovigilance of Covid-19 vaccine (ChAdOx1-S [recombinant]) at Bio-Manguinhos/Fiocruz
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Pharmacovigilance of biotechnological therapies: how Bio-Manguinhos has been preparing itself for the challenges that have arisen?
| Date Issued:
2013 | Copyright:
open access
Papers presented at events
Genetic basis for yellow fever vaccine-associated viscerotropic disease (YEL-AVD): a preliminary report
| Date Issued:
2019 | Copyright:
open access
Papers presented at events
Avaliação de eventos adversos recebidos pela farmacovigilância a partir do SAC de Bio-Manguinhos / Fiocruz
| Date Issued:
2015 | Copyright:
open access
Papers presented at events
A phase II, III clinical trial to assess immunogenicity, reactogenicity and safety of the measles, rubella vaccine, produced by Bio-Manguinhos
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Abnormal cellular innate responses in cases of adverse events post yellow fever immunization after in vitro 17DD stimulation
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Immunogenicity and safety of Yellow Fever Vaccine: systematic review and metanalysis
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Type I interferon innate errors causing severe adverse events following yellow fever vaccination: a family-based case study
| Date Issued:
2024 | Copyright:
open access